CompletedPhase 3NCT00046930
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eastern Cooperative Oncology Group
- Principal Investigator
- Larry D. Cripe, MD, MDIndiana University Melvin and Bren Simon Cancer Center
- Intervention
- filgrastim(biological)
- Enrollment
- 449 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 2002
Study locations (30)
- CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital, Aurora, Colorado, United States
- Boulder Community Hospital, Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States
- Porter Adventist Hospital, Denver, Colorado, United States
- Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States
- St. Joseph Hospital, Denver, Colorado, United States
- Rose Medical Center, Denver, Colorado, United States
- CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States
- Swedish Medical Center, Englewood, Colorado, United States
- Sky Ridge Medical Center, Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
- St. Mary-Corwin Regional Medical Center, Pueblo, Colorado, United States
- North Suburban Medical Center, Thornton, Colorado, United States
- University of Florida Shands Cancer Center, Gainesville, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Eli Lilly and Company · Kanisa Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00046930 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.